{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:26:03Z","timestamp":1794029163121,"version":"4.8.0"},"reference-count":248,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Substance use in pregnancy is common; nearly one of five of pregnant individuals have past-month nicotine, alcohol, or illicit substance use, and more than one in 10 meet criteria for a substance use disorder (SUD). Substance use disorders are among the most stigmatized and poorly understood medical conditions, particularly in the perinatal period. The obstetrician\u2013gynecologist (ob-gyn) is a critical member of the health care and social support team for pregnant and postpartum individuals with SUD. Yet, many do not feel knowledgeable in screening and treating SUD, hampering efforts to identify and treat this population. In this review, we focus on practices that ob-gyns can incorporate into daily care. We start with the unique vulnerabilities of the perinatal period and discuss overdose as a leading cause of maternal death in the United States. We then review the basic tenets of addiction medicine including person-centered language and current medical terminology as well as best practices for substance use screening. We provide a review of maternal, fetal, and child effects of the most common substances including tobacco, alcohol, cannabis, opioids, stimulants, and benzodiazepines and their respective treatment recommendations, so that ob-gyns can incorporate basic addiction management into their daily practice.<\/jats:p>","DOI":"10.1097\/aog.0000000000004657","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T17:11:38Z","timestamp":1641489098000},"page":"317-337","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["What Obstetrician\u2013Gynecologists Should Know About Substance Use Disorders in the Perinatal Period"],"prefix":"10.1097","volume":"139","author":[{"given":"Marcela C.","family":"Smid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"R2-20261107","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archpsyc.65.7.805","article-title":"Psychiatric disorders in pregnant and postpartum women in the United States","volume":"65","author":"Vesga-L\u00f3pez","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R3-20261107","doi-asserted-by":"crossref","first-page":"912","DOI":"10.15288\/jsa.2000.61.912","article-title":"A national survey of training in substance use disorders in residency programs","volume":"61","author":"Isaacson","year":"2000","journal-title":"J Stud Alcohol"},{"key":"R4-20261107","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s40596-019-01018-w","article-title":"Current trends in psychiatric education among obstetrics and gynecology residency programs","volume":"43","author":"Garbarino","year":"2019","journal-title":"Acad Psychiatry"},{"key":"R5-20261107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2015.02.027","article-title":"Perinatal substance use: a prospective evaluation of abstinence and relapse","volume":"150","author":"Forray","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R6-20261107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11920-015-0626-5","article-title":"Substance use in the perinatal period","volume":"17","author":"Forray","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"R7-20261107","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/10550887.2012.735566","article-title":"Pregnant and non-pregnant women with substance use disorders: the gap between treatment need and receipt","volume":"31","author":"Terplan","year":"2012","journal-title":"J Addict Dis"},{"key":"R8-20261107","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2215-0366(14)70333-5","article-title":"Progesterone reduces cocaine use in postpartum women with a cocaine use disorder: a randomized, double-blind study","volume":"1","author":"Yonkers","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"R9-20261107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psyneuen.2017.09.012","article-title":"Progesterone for smoking relapse prevention following delivery: a pilot, randomized, double-blind study","volume":"86","author":"Forray","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"R10-20261107","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1037\/a0021265","article-title":"Role of progesterone in nicotine addiction: evidence from initiation to relapse","volume":"18","author":"Lynch","year":"2010","journal-title":"Exp Clin Psychopharmacol"},{"key":"R11-20261107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40263-018-0525-5","article-title":"Role of exogenous progesterone in the treatment of men and women with substance use disorders: a narrative review","volume":"32","author":"Peltier","year":"2018","journal-title":"CNS Drugs"},{"key":"R12-20261107","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/ntr\/ntw156","article-title":"Progesterone and postpartum smoking relapse: a pilot double-blind placebo-controlled randomized trial","volume":"18","author":"Allen","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"R14-20261107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1744-8069-9-45","article-title":"Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors","volume":"9","author":"Lee","year":"2013","journal-title":"Mol Pain"},{"key":"R15-20261107","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fnins.2015.00466","article-title":"Sex differences in kappa opioid receptor function and their potential impact on addiction","volume":"9","author":"Chartoff","year":"2015","journal-title":"Front Neurosci"},{"key":"R16-20261107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/npp.2015.272","article-title":"Translational studies of sex differences in sensitivity to opioid addiction","volume":"41","author":"Chartoff","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"R17-20261107","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R18-20261107","first-page":"1","article-title":"\u201cIf only I could have said, if only somebody was listening\u201d: mothers' experiences of placing their child into care","author":"Siverns","year":"2021","journal-title":"Adoption Q"},{"key":"R19-20261107","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2850.2008.01324.x","article-title":"Nursing the disenfranchised: women who have relinquished an infant for adoption","volume":"16","author":"Aloi","year":"2009","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"R20-20261107","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2105\/AJPH.2016.303473","article-title":"Deaths from unintentional injury, homicide, and suicide during or within 1 year of pregnancy in Philadelphia","volume":"106","author":"Mehta","year":"2016","journal-title":"Am J Public Health"},{"key":"R21-20261107","first-page":"34","article-title":"On the future of maternal mortality review in Rhode Island","volume":"101","author":"Spelke","year":"2018","journal-title":"R I Med J (2013)"},{"key":"R22-20261107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jwh.2017.6800","article-title":"Building U.S. capacity to review and prevent maternal deaths","volume":"27","author":"Zaharatos","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"R23-20261107","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/AOG.0000000000002417","article-title":"Challenges and opportunities in identifying, reviewing, and preventing maternal deaths","volume":"131","author":"St Pierre","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R24-20261107","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.whi.2017.05.002","article-title":"Initiation and engagement with methadone treatment among pregnant and postpartum women","volume":"27","author":"Mattocks","year":"2017","journal-title":"Women's Health Issues"},{"key":"R25-20261107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/01612840152053110","article-title":"Factors affecting substance abuse treatment completion for women","volume":"22","author":"Kelly","year":"2001","journal-title":"Issues Ment Health Nurs"},{"key":"R26-20261107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/08897077.2019.1671296","article-title":"The intersection of intimate partner violence and substance use among women with opioid use disorder","volume":"42","author":"Pallatino","year":"2021","journal-title":"Subst Abus"},{"key":"R27-20261107","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10826084.2017.1327976","article-title":"Postpartum contraceptive use and rapid repeat pregnancy among women who use substances","volume":"53","author":"Loree","year":"2018","journal-title":"Subst Use Misuse"},{"key":"R28-20261107","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ypmed.2015.04.008","article-title":"Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review","volume":"80","author":"Terplan","year":"2015","journal-title":"Prev Med"},{"key":"R29-20261107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/ADM.0000000000000471","article-title":"Pregnancy intention, risk perception, and contraceptive use in pregnant women who use drugs","volume":"13","author":"MacAfee","year":"2019","journal-title":"J Addict Med"},{"key":"R30-20261107","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R31-20261107","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","article-title":"Trends in pregnancy-associated mortality involving opioids in the United States, 2007-2016","volume":"220","author":"Gemmill","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R32-20261107","first-page":"614","article-title":"Maternal mortality in Texas","volume":"34","author":"Baeva","year":"2017","journal-title":"Am J Perinatol"},{"key":"R34-20261107","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/AOG.0000000000004066","article-title":"Pregnancy-associated mortality due to accidental drug overdose and suicide in Ohio 2009-2018","volume":"136","author":"Hall","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R35-20261107","doi-asserted-by":"crossref","first-page":"489.e1","DOI":"10.1016\/j.ajog.2019.05.045","article-title":"Maternal drug-related death and suicide are leading causes of postpartum death in California","volume":"221","author":"Goldman-Mellor","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20261107","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/AOG.0000000000003988","article-title":"Standardized criteria for review of perinatal suicides and accidental drug-related deaths","volume":"136","author":"Smid","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R37-20261107","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/AOG.0b013e31822c9906","article-title":"At-risk drinking and alcohol dependence: obstetric and gynecologic implications. Committee Opinion No. 496. American College of Obstetricians and Gynecologists","volume":"118","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R38-20261107","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/AOG.0000000000003279","article-title":"Pregnancy-associated death in UT: contribution of drug-induced deaths","volume":"133","author":"Smid","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R40-20261107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/add.14825","article-title":"Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery","volume":"115","author":"Nielsen","year":"2020","journal-title":"Addiction"},{"key":"R41-20261107","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/AOG.0000000000002633","article-title":"Optimizing postpartum care. ACOG Committee Opinion No. 736. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R42-20261107","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R45-20261107","first-page":"77","article-title":"Healthy mothers, healthy babies: a reproductive justice response to the womb-to-foster-care pipeline","volume":"20","author":"Ketteringham","year":"2016","journal-title":"CUNY L Rev"},{"key":"R46-20261107","first-page":"125","article-title":"The racial geography of child welfare: toward a new research paradigm","volume":"87","author":"Roberts","year":"2008","journal-title":"Child Welfare"},{"key":"R48-20261107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s007370050014","article-title":"Maintenance therapy with synthetic opioids within a multidisciplinary program \u2013 a stabilizing necessity for pregnant opioid dependent women","volume":"1","author":"Fischer","year":"1998","journal-title":"Arch Women's Ment Health"},{"key":"R49-20261107","first-page":"179","article-title":"Residential substance abuse treatment for pregnant and postpartum women and their children: treatment and policy implications","volume":"80","author":"Clark","year":"2001","journal-title":"Child Welfare"},{"key":"R50-20261107","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ADM.0000000000000534","article-title":"Continuation in treatment and maintenance of custody of newborns after delivery in women with opioid use disorder","volume":"14","author":"Schauberger","year":"2020","journal-title":"J Addict Med"},{"key":"R52-20261107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/16066359.2021.1875215","article-title":"Changing the narrative: a call to end stigmatizing terminology related to substance use disorders","volume":"29","author":"Atayde","year":"2021","journal-title":"Addict Res Theor"},{"key":"R53-20261107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ADM.0000000000000178","article-title":"International statement recommending against the use of terminology that can stigmatize people","volume":"10","author":"Saitz","year":"2016","journal-title":"J Addict Med"},{"key":"R54-20261107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6620a1","article-title":"Receipt of selected preventive health services for women and men of reproductive age - United States, 2011-2013","volume":"66","author":"Pazol","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"R55-20261107","doi-asserted-by":"crossref","first-page":"141.e1","DOI":"10.1016\/j.ajog.2012.11.017","article-title":"Psychosocial risk, prenatal counseling and maternal behavior: findings from PRAMS, 2004-2008","volume":"208","author":"Krans","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R56-20261107","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41372-019-0542-3","article-title":"Obstetrician-gynecologists' practices and attitudes on substance use screening during pregnancy","volume":"40","author":"Ko","year":"2019","journal-title":"J Perinatol"},{"key":"R57-20261107","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ajog.2016.06.038","article-title":"The role of screening, brief intervention, and referral to treatment in the perinatal period","volume":"215","author":"Wright","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R58-20261107","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.chiabu.2003.07.004","article-title":"Patients' characteristics and providers' attitudes: predictors of screening pregnant women for illicit substance use","volume":"28","author":"Kerker","year":"2004","journal-title":"Child Abuse Negl"},{"key":"R59-20261107","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","article-title":"Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the Society for Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists, and American Society of Addiction Medicine","volume":"221","author":"Ecker","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R62-20261107","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s10995-020-03006-1","article-title":"Secrecy versus disclosure: women with substance use disorders share experiences in help seeking during pregnancy","volume":"24","author":"Paris","year":"2020","journal-title":"Matern Child Health J"},{"key":"R63-20261107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health & Justice"},{"key":"R64-20261107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.chiabu.2018.01.026","article-title":"Perceptions of child protective services among pregnant or recently pregnant, opioid-using women in substance abuse treatment","volume":"79","author":"Falletta","year":"2018","journal-title":"Child Abuse Negl"},{"key":"R66-20261107","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1360-0443.1999.941014996.x","article-title":"Brief intervention for alcohol use in pregnancy: a randomized trial","volume":"94","author":"Chang","year":"1999","journal-title":"Addiction"},{"key":"R67-20261107","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/01.AOG.0000157109.05453.84","article-title":"Brief intervention for prenatal alcohol use: a randomized trial","volume":"105","author":"Chang","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R68-20261107","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s40501-017-0116-y","article-title":"Pregnancy and the opioid epidemic","volume":"4","author":"Saia","year":"2017","journal-title":"Curr Treat Options Psychiatry"},{"key":"R69-20261107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ADM.0000000000000323","article-title":"Appropriate use of drug testing in clinical addiction medicine","volume":"11","author":"Jarvis","year":"2017","journal-title":"J Addict Med"},{"key":"R70-20261107","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.AOG.0000466371.86393.9b","article-title":"Alcohol abuse and other substance use disorders: ethical issues in obstetric and gynecologic practice. Committee Opinion No. 633. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R71-20261107","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.siny.2019.01.007","article-title":"Screening for substance use in pregnancy and the newborn","volume":"24","author":"Polak","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"R72-20261107","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0000000000003381","article-title":"National partnership for maternal safety: consensus bundle on obstetric care for women with opioid use disorder","volume":"134","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R73-20261107","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11606-012-2165-7","article-title":"They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain","volume":"27","author":"Starrels","year":"2012","journal-title":"J Gen Intern Med"},{"key":"R74-20261107","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5055\/jom.2007.0044","article-title":"Urine drug test interpretation: what do physicians know?","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag"},{"key":"R75-20261107","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5055\/jom.2007.0022","article-title":"Family physicians' proficiency in urine drug test interpretation","volume":"3","author":"Reisfield","year":"2007","journal-title":"J Opioid Manag"},{"key":"R77-20261107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0897190010380463","article-title":"Interferences with urine drug screens","volume":"24","author":"Herring","year":"2011","journal-title":"J Pharm Pract"},{"key":"R78-20261107","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/AOG.0000000000001781","article-title":"Neonatal abstinence syndrome and ethical approaches to the identification of pregnant women who use drugs","volume":"129","author":"Terplan","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R79-20261107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40429-017-0132-4","article-title":"Psychiatric co-morbidities in pregnant women with opioid use disorders: prevalence, impact, and implications for treatment","volume":"4","author":"Arnaudo","year":"2017","journal-title":"Curr Addict Rep"},{"key":"R81-20261107","doi-asserted-by":"crossref","first-page":"833","DOI":"10.15585\/mmwr.mm6839a1","article-title":"National trends in hepatitis C infection by opioid use disorder status among pregnant women at delivery hospitalization - United States, 2000-2015","volume":"68","author":"Ko","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R82-20261107","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.2018.16789","article-title":"Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"R83-20261107","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/AOG.0b013e318249ff74","article-title":"Intimate partner violence. Committee Opinion No. 518. American College of Obstetricians and Gynecologists","volume":"119","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R86-20261107","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R87-20261107","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"key":"R88-20261107","doi-asserted-by":"crossref","first-page":"107679","DOI":"10.1016\/j.drugalcdep.2019.107679","article-title":"Unmet substance use disorder treatment need among reproductive age women","volume":"206","author":"Martin","year":"2020","journal-title":"Drug and alcohol dependence"},{"key":"R89-20261107","doi-asserted-by":"crossref","first-page":"e205734","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Netw open"},{"key":"R90-20261107","doi-asserted-by":"crossref","first-page":"108454","DOI":"10.1016\/j.jsat.2021.108454","article-title":"Racial inequity in methadone dose at delivery in pregnant women with opioid use disorder","volume":"131","author":"Rosenthal","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"R91-20261107","doi-asserted-by":"crossref","first-page":"108236","DOI":"10.1016\/j.drugalcdep.2020.108236","article-title":"Substance use disorders and risk of severe maternal morbidity in the United States","volume":"216","author":"Jarlenski","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R92-20261107","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/ADM.0000000000000792","article-title":"Co-occurring substance use disorders identified among delivery hospitalizations in the United States","volume":"15","author":"Jarlenski","year":"2020","journal-title":"J Addict Med"},{"key":"R93-20261107","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1542\/peds.2011-3552","article-title":"Breastfeeding and the use of human milk","volume":"129","year":"2012","journal-title":"Pediatrics"},{"key":"R94-20261107","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ypmed.2017.07.030","article-title":"Tobacco and nicotine delivery product use in a national sample of pregnant women","volume":"104","author":"Kurti","year":"2017","journal-title":"Prev Med"},{"key":"R95-20261107","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/ntr\/nty018","article-title":"Patterns of nicotine and tobacco product use in youth and young adults in the United States, 2011-2015","volume":"20","author":"Johnson","year":"2018","journal-title":"Nicotine Tob Res"},{"key":"R96-20261107","first-page":"1","article-title":"Cigarette smoking during pregnancy: United States, 2016","author":"Drake","year":"2018","journal-title":"NCHS Data Brief"},{"key":"R98-20261107","first-page":"93","article-title":"Tobacco and ectopic pregnancy. Arguments in favor of a causal relation [in French]","volume":"46","author":"Bouyer","year":"1998","journal-title":"Rev Epidemiol Sante Publique"},{"key":"R99-20261107","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00404-010-1447-8","article-title":"Association between tobacco use in pregnancy and placenta-associated syndromes: a population-based study","volume":"283","author":"Aliyu","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"R100-20261107","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1177\/1933719114556486","article-title":"Smoking and preterm birth","volume":"22","author":"Ion","year":"2015","journal-title":"Reprod Sci"},{"key":"R101-20261107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.amepre.2010.03.009","article-title":"Infant morbidity and mortality attributable to prenatal smoking in the U.S","volume":"39","author":"Dietz","year":"2010","journal-title":"Am J Prev Med"},{"key":"R102-20261107","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1055\/s-0039-1693689","article-title":"Smoking during pregnancy and adverse birth and maternal outcomes in California, 2007 to 2016","volume":"37","author":"Ratnasiri","year":"2020","journal-title":"Am J Perinatol"},{"key":"R103-20261107","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1001\/jama.2020.6647","article-title":"Smoking cessation-progress, barriers, and new opportunities: the Surgeon general's report on smoking cessation","volume":"323","author":"Adams","year":"2020","journal-title":"JAMA"},{"key":"R106-20261107","first-page":"1","article-title":"Trends in smoking before, during, and after pregnancy--pregnancy risk assessment monitoring system, United States, 40 sites 2000-2010","volume":"62","author":"Tong","year":"2013","journal-title":"MMWR Surveill Summ"},{"key":"R108-20261107","first-page":"273","article-title":"Sex differences in smoking cessation pharmacotherapy comparative efficacy: a Network meta-analysis","volume":"19","author":"Smith","year":"2017","journal-title":"Nicotine Tob Res"},{"key":"R109-20261107","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ntr\/ntv207","article-title":"Sex differences in varenicline efficacy for smoking cessation: a meta-analysis","volume":"18","author":"McKee","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"R112-20261107","doi-asserted-by":"crossref","first-page":"420.e1","DOI":"10.1016\/j.ajog.2016.11.1036","article-title":"Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial","volume":"216","author":"Nanovskaya","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R113-20261107","first-page":"351","article-title":"Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions","volume":"32","author":"Stotts","year":"2015","journal-title":"Am J Perinatol"},{"key":"R114-20261107","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/ntr\/nty055","article-title":"Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy","volume":"21","author":"Turner","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"R115-20261107","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/thx.2007.090647","article-title":"Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial","volume":"63","author":"Aubin","year":"2008","journal-title":"Thorax"},{"key":"R116-20261107","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/jwh.2006.0281","article-title":"Treating tobacco dependence in women","volume":"16","author":"Schnoll","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"R117-20261107","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/NDT.S927","article-title":"Varenicline in the treatment of tobacco dependence","volume":"4","author":"Fagerstr\u00f6m","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R118-20261107","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-011-2327-z","article-title":"Varenicline effects on craving, cue reactivity, and smoking reward","volume":"218","author":"Brandon","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"R119-20261107","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1542\/peds.2013-3319","article-title":"Prevalence and characteristics of fetal alcohol spectrum disorders","volume":"134","author":"May","year":"2014","journal-title":"Pediatrics"},{"key":"R120-20261107","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/acer.14314","article-title":"Fetal alcohol spectrum disorders in a midwestern city: child characteristics, maternal risk traits, and prevalence","volume":"44","author":"May","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"R122-20261107","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/bdr2.1589","article-title":"National population-based estimates for major birth defects, 2010-2014","volume":"111","author":"Mai","year":"2019","journal-title":"Birth Defects Res"},{"key":"R123-20261107","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0892-0362(95)00005-C","article-title":"An update on incidence of FAS: FAS is not an equal opportunity birth defect","volume":"17","author":"Abel","year":"1995","journal-title":"Neurotoxicol Teratol"},{"key":"R124-20261107","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMra1407298","article-title":"Recognition and management of withdrawal delirium (delirium tremens)","volume":"371","author":"Schuckit","year":"2014","journal-title":"N Engl J Med"},{"key":"R125-20261107","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.164.13.1405","article-title":"Management of alcohol withdrawal delirium. An evidence-based practice guideline","volume":"164","author":"Mayo-Smith","year":"2004","journal-title":"Arch Intern Med"},{"key":"R126-20261107","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ADM.0000000000000635","article-title":"Executive summary of the focused update of the ASAM national practice guideline for the treatment of opioid use disorder","volume":"14","author":"Crotty","year":"2020","journal-title":"J Addict Med"},{"key":"R127-20261107","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1530-0277.2011.01451.x","article-title":"Long-term mortality of patients admitted to the hospital with alcohol withdrawal syndrome","volume":"35","author":"Campos","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"R129-20261107","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"JAMA"},{"key":"R131-20261107","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/HRP.0000000000000070","article-title":"Alcohol use disorders in pregnancy","volume":"23","author":"DeVido","year":"2015","journal-title":"Harv Rev Psychiatry"},{"key":"R132-20261107","doi-asserted-by":"crossref","first-page":"107452","DOI":"10.1016\/j.yebeh.2020.107452","article-title":"Current legal status of medical marijuana and cannabidiol in the United States","volume":"112","author":"Alharbi","year":"2020","journal-title":"Epilepsy Behav"},{"key":"R133-20261107","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2018.12.009","article-title":"Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009-2016","volume":"196","author":"Young-Wolff","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R134-20261107","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.15585\/mmwr.mm6932a2","article-title":"Characteristics of marijuana use during pregnancy - eight states, pregnancy risk assessment monitoring system, 2017","volume":"69","author":"Ko","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R135-20261107","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jogc.2020.09.017","article-title":"Opioid and cannabis use during pregnancy and breastfeeding in relation to sociodemographics and mental health status: a descriptive study","volume":"43","author":"Grywacheski","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"R136-20261107","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2105\/AJPH.2017.303825","article-title":"Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons","volume":"107","author":"Jarlenski","year":"2017","journal-title":"Am J Public Health"},{"key":"R137-20261107","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2147\/IJWH.S266540","article-title":"Perceived risk of weekly cannabis use, past 30-day cannabis use, and frequency of cannabis use among pregnant women in the United States","volume":"12","author":"Odom","year":"2020","journal-title":"Int J Womens Health"},{"key":"R138-20261107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.11.028","article-title":"Beliefs and attitudes regarding prenatal marijuana use: perspectives of pregnant women who report use","volume":"196","author":"Chang","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R139-20261107","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/brainsci8030040","article-title":"The effects of cannabinoids on executive functions: evidence from cannabis and synthetic cannabinoids-a systematic review","volume":"8","author":"Cohen","year":"2018","journal-title":"Brain Sci"},{"key":"R140-20261107","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa1610300","article-title":"\"Zombie\" outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York","volume":"376","author":"Adams","year":"2017","journal-title":"N Engl J Med"},{"key":"R141-20261107","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa1807652","article-title":"An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois","volume":"379","author":"Kelkar","year":"2018","journal-title":"N Engl J Med"},{"key":"R142-20261107","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/15563650.2019.1647344","article-title":"Characteristics and circumstances of synthetic cannabinoid-related death","volume":"58","author":"Darke","year":"2020","journal-title":"Clin Toxicol (Phila)"},{"key":"R143-20261107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.9740\/mhc.2019.03.093","article-title":"Review of the many faces of synthetic cannabinoid toxicities","volume":"9","author":"Alipour","year":"2019","journal-title":"Ment Health Clin"},{"key":"R144-20261107","first-page":"1002","article-title":"Synthetic cannabinoid and synthetic cocaine use during pregnancy in a soldier","volume":"1","author":"Berry-Cab\u00e1n","year":"2013","journal-title":"J Subst Abuse Alcohol"},{"key":"R145-20261107","first-page":"25","article-title":"Neonatal outcome after the use of synthetic cannabinoid Bonzai in pregnancy: a case report and brief review of literature","volume":"48","author":"\u00d6zt\u00fcrk","year":"2017","journal-title":"Acta Med"},{"key":"R146-20261107","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/AOG.0000000000002354","article-title":"Marijuana use during pregnancy and lactation. Committee Opinion No. 722. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R148-20261107","doi-asserted-by":"crossref","first-page":"e20181889","DOI":"10.1542\/peds.2018-1889","article-title":"Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes [published erratum appears in Pediatrics 2018 Aug 27]","volume":"142","author":"Ryan","year":"2018","journal-title":"Pediatrics"},{"key":"R149-20261107","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M19-1105","article-title":"Pharmacotherapy for the treatment of cannabis use disorder: a systematic review","volume":"172","author":"Kondo","year":"2020","journal-title":"Ann Intern Med"},{"key":"R150-20261107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1521-0391.2009.00027.x","article-title":"N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study","volume":"19","author":"Gray","year":"2010","journal-title":"Am J Addict"},{"key":"R151-20261107","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/npp.2012.14","article-title":"A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults","volume":"37","author":"Mason","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"R152-20261107","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/phar.1747","article-title":"Treatment of cannabis use disorder: current science and future outlook","volume":"36","author":"Sherman","year":"2016","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"R153-20261107","doi-asserted-by":"crossref","first-page":"e20164131","DOI":"10.1542\/peds.2016-4131","article-title":"Maternal use of opioids during pregnancy and congenital malformations: a systematic review","volume":"139","author":"Lind","year":"2017","journal-title":"Pediatrics"},{"key":"R154-20261107","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"key":"R155-20261107","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"R156-20261107","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: stillbirth incidence with a case report","volume":"116","author":"Rementeri\u00e1","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"R157-20261107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2016.03.015","article-title":"Detoxification from opiate drugs during pregnancy","volume":"215","author":"Bell","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R158-20261107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000381670","article-title":"Tapering from methadone or buprenorphine during pregnancy: maternal and neonatal outcomes in Norway 1996-2009","volume":"21","author":"Welle-Strand","year":"2015","journal-title":"Eur Addict Res"},{"key":"R159-20261107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehaviour","volume":"22","author":"Jansson","year":"2009","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R160-20261107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","article-title":"Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes","volume":"122","author":"Jansson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"R161-20261107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicol Teratol"},{"issue":"suppl 1","key":"R162-20261107","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before and after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction (Abingdon, England)"},{"key":"R163-20261107","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jsgi.2005.11.001","article-title":"Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns","volume":"13","author":"Ramirez-Cacho","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"R164-20261107","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3109\/14767058.2010.536863","article-title":"Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates","volume":"24","author":"Leeman","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R165-20261107","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"R166-20261107","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/jama.2018.2640","article-title":"Neonatal abstinence syndrome: advances in diagnosis and treatment","volume":"319","author":"Wachman","year":"2018","journal-title":"JAMA"},{"key":"R167-20261107","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/jp.2014.114","article-title":"Variation in treatment of neonatal abstinence syndrome in US children's hospitals, 2004-2011","volume":"34","author":"Patrick","year":"2014","journal-title":"J Perinatol"},{"key":"R168-20261107","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamapediatrics.2018.5044","article-title":"Pharmacological treatments for neonatal abstinence syndrome: a systematic review and Network meta-analysis","volume":"173","author":"Disher","year":"2019","journal-title":"JAMA Pediatr"},{"key":"R169-20261107","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1080\/14767058.2018.1465038","article-title":"The effect of standardizing treatment when managing neonatal abstinence syndrome","volume":"32","author":"Burnette","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R170-20261107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ADM.0000000000000183","article-title":"Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study: Re: Meyer et al","volume":"10","author":"McCarthy","year":"2016","journal-title":"J Addict Med"},{"key":"R171-20261107","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"key":"R172-20261107","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome","volume":"157","author":"Seligman","year":"2010","journal-title":"J Pediatr"},{"key":"R173-20261107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000441220","article-title":"Maternal buprenorphine dose at delivery and its relationship to neonatal outcomes","volume":"22","author":"O'Connor","year":"2016","journal-title":"Eur Addict Res"},{"key":"R174-20261107","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ADM.0000000000000427","article-title":"Does maternal buprenorphine dose affect severity or incidence of neonatal abstinence syndrome?","volume":"12","author":"Wong","year":"2018","journal-title":"J Addict Med"},{"key":"R176-20261107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction","volume":"10","author":"Dugosh","year":"2016","journal-title":"J Addict Med"},{"key":"R177-20261107","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1176\/appi.ajp.2016.16070792","article-title":"The role of behavioral interventions in buprenorphine maintenance treatment: a review","volume":"174","author":"Carroll","year":"2017","journal-title":"Am J Psychiatry"},{"key":"R178-20261107","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1176\/appi.ajp.162.8.1452","article-title":"Behavioral therapies for drug abuse","volume":"162","author":"Carroll","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R179-20261107","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R180-20261107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.drugalcdep.2015.02.012","article-title":"Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder","volume":"149","author":"Wilder","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R181-20261107","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R183-20261107","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2018.1488336","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states","volume":"40","author":"Patrick","year":"2019","journal-title":"Subst Abus"},{"key":"R184-20261107","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/add.15030","article-title":"Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study","volume":"115","author":"Sufrin","year":"2020","journal-title":"Addiction"},{"key":"R185-20261107","doi-asserted-by":"crossref","first-page":"108159","DOI":"10.1016\/j.drugalcdep.2020.108159","article-title":"Medications for opioid use disorder in pregnancy in a state women's prison facility","volume":"214","author":"Knittel","year":"2020","journal-title":"Drug and alcohol dependence"},{"key":"R186-20261107","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13669-016-0168-9","article-title":"Caring for pregnant women with opioid use disorder in the USA: expanding and improving treatment","volume":"5","author":"Saia","year":"2016","journal-title":"Curr Obstet Gynecol Rep"},{"key":"R187-20261107","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0000000000001446","article-title":"Opioid use disorder in pregnancy: health policy and practice in the midst of an epidemic","volume":"128","author":"Krans","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R189-20261107","doi-asserted-by":"crossref","first-page":"100451","DOI":"10.1016\/j.ajogmf.2021.100451","article-title":"Buprenorphine X-waiver exemption - beyond the basics for the obstetrical provider","volume":"3","author":"Cleary","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R190-20261107","doi-asserted-by":"crossref","first-page":"108182","DOI":"10.1016\/j.jsat.2020.108182","article-title":"I have to be around people that are doing what I'm doing\": the importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities","volume":"122","author":"Kleinman","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"R191-20261107","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.02.019","article-title":"Contingency management with community reinforcement approach or twelve-step facilitation drug counseling for cocaine dependent pregnant women or women with young children","volume":"118","author":"Schottenfeld","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"R192-20261107","first-page":"1","article-title":"A comparison of patients with opioid use disorder receiving buprenorphine treatment with and without peer recovery support services","author":"Mills Huffnagle","year":"2021","journal-title":"J Substance Use"},{"key":"R193-20261107","doi-asserted-by":"crossref","first-page":"106204","DOI":"10.1016\/j.addbeh.2019.106204","article-title":"Peer support specialists and perinatal opioid use disorder: someone that's been there, lived it, seen it","volume":"102","author":"Fallin-Bennett","year":"2020","journal-title":"Addict Behav"},{"key":"R194-20261107","doi-asserted-by":"crossref","first-page":"108215","DOI":"10.1016\/j.jsat.2020.108215","article-title":"Telehealth sustains patient engagement in OUD treatment during COVID-19","volume":"122","author":"Langabeer","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"R195-20261107","article-title":"Virtual twelve step meeting attendance during the COVID-19 period: a study of members of narcotics anonymous","author":"Galanter","year":"2021","journal-title":"J Addict Med"},{"key":"R196-20261107","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/ajo.12761","article-title":"Managing opioid overdose in pregnancy with take-home naloxone","volume":"58","author":"Blandthorn","year":"2018","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R197-20261107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/08897077.2018.1449053","article-title":"Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply","volume":"40","author":"Bell","year":"2019","journal-title":"Subst Abus"},{"key":"R198-20261107","doi-asserted-by":"crossref","first-page":"107896","DOI":"10.1016\/j.drugalcdep.2020.107896","article-title":"Legal requirements and recommendations to prescribe naloxone","volume":"209","author":"Haffajee","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"R199-20261107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.puhe.2019.11.014","article-title":"Coprescription of opioid and naloxone in office-based practice and emergency department settings in the United States","volume":"180","author":"Sohn","year":"2020","journal-title":"Public Health"},{"key":"R200-20261107","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/AOG.0000000000002562","article-title":"Opioid detoxification during pregnancy: a systematic review","volume":"131","author":"Terplan","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R201-20261107","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0892-0362(93)90024-I","article-title":"Saying \"goodbye\" to the \"crack baby","volume":"15","author":"Coles","year":"1993","journal-title":"Neurotoxicology and teratology"},{"key":"R202-20261107","first-page":"1","article-title":"Prenatal substance use: exploring assumptions of maternal unfitness","volume":"9","author":"Terplan","year":"2015","journal-title":"Substance Abuse"},{"key":"R203-20261107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/tera.1420440407","article-title":"Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis","volume":"44","author":"Lutiger","year":"1991","journal-title":"Teratology"},{"key":"R204-20261107","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0002-9378(86)80044-8","article-title":"Hemodynamic effects of intravenous cocaine on the pregnant Ewe and fetus","volume":"155","author":"Moore","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"R205-20261107","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jama.1987.03390070077027","article-title":"Effect of cocaine on uterine blood flow and fetal oxygenation","volume":"257","author":"Woods","year":"1987","journal-title":"JAMA"},{"key":"R206-20261107","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0892-0362(99)00022-7","article-title":"Cocaine decreases uteroplacental blood flow in the rat","volume":"21","author":"Patel","year":"1999","journal-title":"Neurotoxicology and teratology"},{"key":"R207-20261107","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/CIRCULATIONAHA.107.188950","article-title":"Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology","volume":"117","author":"McCord","year":"2008","journal-title":"Circulation"},{"key":"R208-20261107","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2007.04.049","article-title":"Crack whips the heart: a review of the cardiovascular toxicity of cocaine","volume":"100","author":"Afonso","year":"2007","journal-title":"Am J Cardiol"},{"key":"R209-20261107","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder-a systematic review and meta-analysis","volume":"34","author":"Chan","year":"2019","journal-title":"J Gen Intern Med"},{"key":"R210-20261107","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine use disorder\u2014a systematic review and meta-analysis","volume":"34","author":"Chan","year":"2019","journal-title":"J Gen Intern Med"},{"key":"R212-20261107","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7517-9-5","article-title":"Implementation and evaluation of a harm-reduction model for clinical care of substance using pregnant women","volume":"9","author":"Wright","year":"2012","journal-title":"Harm Reduction J"},{"key":"R213-20261107","first-page":"25802420986707","article-title":"Methamphetamine deaths: changing trends and diagnostic issues","volume":"61","author":"Lewis","year":"2021","journal-title":"Med Sci L"},{"key":"R214-20261107","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine- and opioid-affected births: incidence, outcomes, and costs, United States, 2004-2015","volume":"109","author":"Admon","year":"2019","journal-title":"Am J Public Health"},{"key":"R215-20261107","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1542\/peds.2005-2564","article-title":"The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth","volume":"118","author":"Smith","year":"2006","journal-title":"Pediatrics"},{"key":"R216-20261107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ntt.2007.09.005","article-title":"Prenatal methamphetamine use and neonatal neurobehavioral outcome","volume":"30","author":"Smith","year":"2008","journal-title":"Neurotoxicol Teratol"},{"key":"R217-20261107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/08897077.2013.814614","article-title":"Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study","volume":"35","author":"Kiblawi","year":"2014","journal-title":"Subst Abus"},{"key":"R218-20261107","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ntt.2010.10.004","article-title":"Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine","volume":"33","author":"Smith","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"R219-20261107","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40263-020-00711-x","article-title":"Pharmacological treatment of methamphetamine\/amphetamine dependence: a systematic review","volume":"34","author":"Siefried","year":"2020","journal-title":"CNS drugs"},{"key":"R220-20261107","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jad.2020.03.014","article-title":"Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: a systematic review and meta-analysis","volume":"269","author":"Bais","year":"2020","journal-title":"J affective Disord"},{"key":"R221-20261107","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.7326\/M19-3249","article-title":"Trends in opioid and psychotropic prescription in pregnancy in the United States from 2001 to 2015 in a privately insured population: a cross-sectional study","volume":"173","author":"Venkatesh","year":"2020","journal-title":"Ann Intern Med"},{"key":"R222-20261107","doi-asserted-by":"crossref","first-page":"e180919","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in medicare Part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"R223-20261107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40261-016-0397-8","article-title":"Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995","volume":"36","author":"Murphy","year":"2016","journal-title":"Clin Drug Invest"},{"key":"R225-20261107","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YIC.0000000000000276","article-title":"Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis","volume":"34","author":"Shinfuku","year":"2019","journal-title":"Int Clin Psychopharmacol"},{"key":"R226-20261107","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/add.14886","article-title":"Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine","volume":"115","author":"Park","year":"2020","journal-title":"Addiction"},{"key":"R228-20261107","doi-asserted-by":"crossref","first-page":"18r12412","DOI":"10.4088\/JCP.18r12412","article-title":"Benzodiazepine use during pregnancy alone or in combination with an antidepressant and congenital malformations: systematic review and meta-analysis","volume":"80","author":"Grigoriadis","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"R229-20261107","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1701-2163(16)34772-7","article-title":"The fetal safety of benzodiazepines: an updated meta-analysis","volume":"33","author":"Enato","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"R230-20261107","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(77)80785-3","article-title":"Withdrawal symptoms in neonates from intrauterine exposure to diazepam","volume":"90","author":"Rementer\u00eda","year":"1977","journal-title":"J Pediatr"},{"key":"R231-20261107","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","article-title":"Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant","volume":"53","author":"Iqbal","year":"2002","journal-title":"Psychiatr Serv (Washington, DC)"},{"key":"R232-20261107","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2008.06.088","article-title":"Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates","volume":"199","author":"Seligman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R233-20261107","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0890-6238(94)90029-9","article-title":"The effects of benzodiazepine use during pregnancy and lactation","volume":"8","author":"McElhatton","year":"1994","journal-title":"Reprod Toxicol"},{"key":"R234-20261107","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1192\/bjp.189.3.213","article-title":"Strategies for discontinuing long-term benzodiazepine use: meta-analysis","volume":"189","author":"Voshaar","year":"2006","journal-title":"Br J Psychiatry"},{"key":"R235-20261107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.genhosppsych.2018.12.005","article-title":"Benzodiazepine withdrawal in pregnant women with opioid use disorders: an observational study of current clinical practices at a tertiary obstetrical hospital","volume":"57","author":"Gopalan","year":"2019","journal-title":"Gen Hosp Psychiatry"},{"key":"R236-20261107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpp.556","article-title":"Cognitive-behavioural, pharmacological and psychosocial predictors of outcome during tapered discontinuation of benzodiazepine","volume":"15","author":"O'Connor","year":"2008","journal-title":"Clin Psychol psychotherapy"},{"key":"R237-20261107","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1097\/ANC.0000000000000462","article-title":"Neonatal abstinence syndrome: exploring nurses' attitudes, knowledge, and practice","volume":"18","author":"Romisher","year":"2018","journal-title":"Adv neonatal Care"},{"key":"R238-20261107","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/08897077.2017.1356423","article-title":"Trainees' knowledge, attitudes, and practices towards caring for the substance-exposed mother-infant dyad","volume":"38","author":"Schiff","year":"2017","journal-title":"Substance abuse"},{"key":"R239-20261107","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J pain (London, England)"},{"key":"R240-20261107","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R241-20261107","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ajog.2013.10.010","article-title":"Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers","volume":"210","author":"Jones","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R242-20261107","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jsat.2010.06.012","article-title":"Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms","volume":"39","author":"Tsui","year":"2010","journal-title":"J substance abuse Treat"},{"key":"R243-20261107","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11606-020-06115-3","article-title":"Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and practice recommendations","volume":"35","author":"Buresh","year":"2020","journal-title":"J Gen Intern Med"},{"key":"R244-20261107","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/appi.ps.201400047","article-title":"Peer recovery support for individuals with substance use disorders: assessing the evidence","volume":"65","author":"Reif","year":"2014","journal-title":"Psychiatr Serv (Washington, DC)"},{"key":"R245-20261107","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.jsat.2021.108450","article-title":"Motherhood, substance use and peer support: benefits of an integrated group program for pregnant and postpartum women","volume":"131","author":"Gru\u00df","year":"2021","journal-title":"J Subst Abuse Treat"},{"key":"R246-20261107","first-page":"1","article-title":"Identified gaps and opportunities in perinatal healthcare delivery for women in treatment for opioid use disorder","author":"Alexander","year":"2020","journal-title":"Subst Abus"},{"key":"R250-20261107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"key":"R251-20261107","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/AOG.0000000000003822","article-title":"Tobacco and nicotine cessation during pregnancy. ACOG Committee Opinion No. 807. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R252-20261107","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US preventive services task force recommendation statement","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"key":"R253-20261107","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archinte.163.7.821","article-title":"Two brief alcohol-screening tests from the alcohol use disorders identification test (AUDIT): validation in a female veterans affairs patient population","volume":"163","author":"Bradley","year":"2003","journal-title":"Arch Intern Med"},{"key":"R254-20261107","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0002-9378(89)90302-5","article-title":"The T-ACE questions: practical prenatal detection of risk-drinking","volume":"160","author":"Sokol","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R255-20261107","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/sj.jp.7211266","article-title":"The 4P's Plus screen for substance use in pregnancy: clinical application and outcomes","volume":"25","author":"Chasnoff","year":"2005","journal-title":"J Perinatol"},{"key":"R257-20261107","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/AOG.0b013e3181ed8290","article-title":"Screening for prenatal substance use: development of the Substance Use Risk Profile-Pregnancy scale","volume":"116","author":"Yonkers","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R258-20261107","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archpedi.153.6.591","article-title":"A new brief screen for adolescent substance abuse","volume":"153","author":"Knight","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R259-20261107","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/j.1360-0443.2012.03982.x","article-title":"Development and preliminary validation of an indirect screener for drug use in the perinatal period","volume":"107","author":"Ondersma","year":"2012","journal-title":"Addiction"},{"key":"R260-20261107","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/AOG.0000000000003230","article-title":"Accuracy of three screening tools for prenatal substance use","volume":"133","author":"Coleman-Cowger","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R261-20261107","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14651","article-title":"Accuracy of five self-report screening instruments for substance use in pregnancy","volume":"114","author":"Ondersma","year":"2019","journal-title":"Addiction"},{"key":"R262-20261107","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","article-title":"High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes","volume":"193","author":"McCarthy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R263-20261107","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4212\/cjhp.v65i5.1176","article-title":"Dosing and monitoring of methadone in pregnancy: literature review","volume":"65","author":"Shiu","year":"2012","journal-title":"Can J Hosp Pharm"},{"key":"R264-20261107","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/ADM.0000000000000099","article-title":"The effect of methadone dose regimen on neonatal abstinence syndrome","volume":"9","author":"McCarthy","year":"2015","journal-title":"J Addict Med"},{"key":"R265-20261107","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"R266-20261107","doi-asserted-by":"crossref","first-page":"e233715","DOI":"10.1136\/bcr-2019-233715","article-title":"Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine\/naloxone for the treatment of opioid use disorder using a microdosing approach","volume":"13","author":"Caulfield","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R267-20261107","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/dar.13113","article-title":"Use of a novel prescribing approach for the treatment of opioid use disorder: buprenorphine\/naloxone micro-dosing - a case series","volume":"39","author":"Brar","year":"2020","journal-title":"Drug Alcohol Rev"},{"key":"R268-20261107","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/ajad.12809","article-title":"Methadone to buprenorphine\/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method","volume":"27","author":"Azar","year":"2018","journal-title":"Am J Addict"},{"key":"R269-20261107","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0272-0590(87)90045-5","article-title":"Toxicity of N-methyl-2-pyrrolidone (NMP): teratogenic, subchronic, and two-year inhalation studies","volume":"9","author":"Lee","year":"1987","journal-title":"Fundam Appl Toxicol"},{"key":"R270-20261107","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0278-6915(02)00300-9","article-title":"Developmental toxicity of N-methyl-2-pyrrolidone in rats following inhalation exposure","volume":"41","author":"Saillenfait","year":"2003","journal-title":"Food Chem Toxicol"},{"key":"R271-20261107","doi-asserted-by":"crossref","first-page":"100179","DOI":"10.1016\/j.ajogmf.2020.100179","article-title":"Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis","volume":"2","author":"Link","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R272-20261107","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R273-20261107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ADM.0000000000000562","article-title":"Buprenorphine and naloxone versus buprenorphine for opioid use disorder in pregnancy: a cohort study","volume":"14","author":"Mullins","year":"2020","journal-title":"J Addict Med"},{"key":"R274-20261107","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ajad.12687","article-title":"Treating women with opioid use disorder during pregnancy in Appalachia: initial neonatal outcomes following buprenorphine+naloxoneexposure","volume":"27","author":"Nguyen","year":"2018","journal-title":"Am J Addict"},{"key":"R275-20261107","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.0004-8666.2002.548_14.x","article-title":"Using naltrexone implants in the management of the pregnant heroin user","volume":"42","author":"Hulse","year":"2002","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R276-20261107","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1479-828X.2001.tb01322.x","article-title":"Obstetric and neonatal outcomes associated with maternal naltrexone exposure","volume":"41","author":"Hulse","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R277-20261107","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.0004-8666.2003.00121.x","article-title":"Naltrexone implant and blood naltrexone levels over pregnancy","volume":"43","author":"Hulse","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R278-20261107","doi-asserted-by":"crossref","first-page":"83.e1","DOI":"10.1016\/j.ajog.2019.07.037","article-title":"Use of naltrexone in treating opioid use disorder in pregnancy","volume":"222","author":"Towers","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R279-20261107","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/AOG.0000000000002864","article-title":"Pregnancy and naltrexone pharmacotherapy","volume":"132","author":"Jones","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R280-20261107","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s40265-017-0762-9","article-title":"A retrospective cohort study of obstetric outcomes in opioid-dependent women treated with implant naltrexone, oral methadone or sublingual buprenorphine, and non-dependent controls","volume":"77","author":"Kelty","year":"2017","journal-title":"Drugs"},{"key":"R281-20261107","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.clinthera.2019.07.003","article-title":"Naltrexone treatment for pregnant women with opioid use disorder compared with matched buprenorphine control subjects","volume":"41","author":"Wachman","year":"2019","journal-title":"Clin Ther"},{"key":"R282-20261107","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijgo.2003.10.001","article-title":"Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user","volume":"85","author":"Hulse","year":"2004","journal-title":"Int J Gynaecol Obstet"},{"key":"R283-20261107","doi-asserted-by":"crossref","first-page":"503","DOI":"10.12968\/bjom.2012.20.7.503","article-title":"The use of naltrexone in pregnancy in opiate-dependent mothers","volume":"20","author":"Geraghty","year":"2012","journal-title":"Br J Midwifery"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:01:35Z","timestamp":1794027695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":248,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004657","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"2021-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}